CarbohydratesCarbohydrates: In humans, powdered amylase inhibitor decreased amylase activity by greater than 96% and increased malabsorption of wheat starch (25). Thus, use of amylase inhibitor may decrease absorption of dietary carbohydrates.
GlucoseGlucose:In humans, amylase inhibitors may reduce postprandial glucose (19; 27; 3). In rats, the use of amylase inhibitors with a starch load decreased postprandial glycemia (20).
MineralsMinerals: In rats, amylase inhibitor increased fecal zinc and copper (26). This may indicate decreased absorption.
The information in this monograph is intended for informational purposes only, and is meant to help users better understand health concerns. Information is based on review of scientific research data, historical practice patterns, and clinical experience. This information should not be interpreted as specific medical advice. Users should consult with a qualified healthcare provider for specific questions regarding therapies, diagnosis and/or health conditions, prior to making therapeutic decisions.